NATICK, Mass., May 24, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 38th Annual Deutsche Bank 2013 Healthcare Conference on May 30 in Boston.
Mike Mahoney, president and chief executive officer, and Jeff Capello, executive vice president and chief financial officer, will participate in a 35-minute question and answer session regarding the Company beginning at approximately 9:20 a.m. ET.
A live webcast of the question and answer session will be available to interested parties via Boston Scientific's website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
This webcast is being hosted by Deutsche Bank. A replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.
About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
CONTACT: Peter Lucht 508-650-8796 (office) Media Relations Boston Scientific Corporation firstname.lastname@example.org
Michael Campbell 508-650-8023 (office) Investor Relations Boston Scientific Corporation email@example.com
SOURCE Boston Scientific Corporation